收稿日期: 2022-02-14
录用日期: 2022-05-16
网络出版日期: 2022-05-28
基金资助
国家自然科学基金(81800230)
Effect of altered expression of long non-coding RNA-B230352I09 on proliferation and cycle of H9C2 cardiomyocytes
Received date: 2022-02-14
Accepted date: 2022-05-16
Online published: 2022-05-28
Supported by
National Natural Science Foundation of China(81800230)
目的·探讨长链非编码RNA-B230352I09(long non-coding RNA-B230352I09,lncRNA-B230352I09)表达改变对H9C2心肌细胞增殖及周期的影响。方法·构建lncRNA-B230352I09过表达载体(pcDNA-B230352I09)和阴性对照(negative control,NC)载体(pcDNA-NC),借助阳离子脂质体Lipofectamine 3000(Lipo3000)转染液将上述构建的载体转染至H9C2心肌细胞。实验分为空白对照组、阴性对照组、lncRNA-B230352I09过表达组,分别通过实时荧光定量聚合酶链反应(real-time fluorescence quantitative polymerase chain reaction,RT-PCR)检测lncRNA-B230352I09的表达量,验证其转染效率;细胞计数试剂盒8(cell counting kit-8,CCK8)检测H9C2心肌细胞在450 nm波长的吸光度(optical density,OD)并绘制生长曲线;5-乙炔基-2'-脱氧尿嘧啶(5-ethynyl-2'-deoxyuridine,EdU)标记增殖期H9C2心肌细胞并通过荧光显微镜观察增殖心肌细胞的数量;流式细胞术分析H9C2心肌细胞在不同细胞周期所占比例;RT-PCR检测H9C2细胞周期相关调控基因的表达情况。结果·与阴性对照组比较,lncRNA-B230352I09过表达组中lncRNA-B230352I09的表达水平显著升高(P=0.000),提示lncRNA-B230352I09转染H9C2心肌细胞模型构建成功。CCK8实验显示,与阴性对照组相比,lncRNA-B230352I09过表达可显著提高H9C2心肌细胞的OD值,促进H9C2心肌细胞增殖,表现为明显的时间依赖性细胞增殖能力增强(24 h:P=0.000;48 h:P=0.000;72 h:P=0.001);荧光显微镜观察发现,与阴性对照组相比,lncRNA-B230352I09过表达组中EdU标记阳性的H9C2心肌细胞比例明显增多;流式细胞术分析显示,和阴性对照组比较,lncRNA-B230352I09过表达组中处于S期的H9C2心肌细胞比例明显增加,G1期心肌细胞的比例下降(P=0.000);RT-PCR检测结果显示,与阴性对照组比较,lncRNA-B230352I09过表达组中H9C2心肌细胞周期蛋白D1(cyclin D1)和细胞周期蛋白依赖性激酶1(cyclin dependent protein kinase 1,CDK1)的mRNA表达水平显著升高(P=0.000)。结论·lncRNA-B230352I09通过调节cyclin D1和CDK1促进心肌细胞进入S期,增强H9C2心肌细胞增殖能力。
关键词: H9C2心肌细胞; 长链非编码RNA-B230352I09; 过表达; 细胞增殖; 细胞周期
徐斐翔 , 汪升 , 薛明明 , 童朝阳 , 陈玉梅 . 长链非编码RNA-B230352I09表达改变对H9C2心肌细胞增殖及周期的影响[J]. 上海交通大学学报(医学版), 2022 , 42(5) : 578 -582 . DOI: 10.3969/j.issn.1674-8115.2022.05.004
·To investigate the effect of altered expression of long non-coding RNA (lncRNA)-B230352I09 on proliferation and cycle of H9C2 cardiomyocytes.
·The lncRNA-B230352I09 overexpression vector (pcDNA-B230352I09) and the negative control vector pcDNA-negative control group (NC) were constructed and transfected into H9C2 cardiomyocytes with the Lipofectamine 3000 (Lipo3000) transfection solution. The expression of lncRNA-B230352I09 was measured by real-time fluorescence quantitative polymerase chain reaction (RT-PCR) to verify its transfection efficiency. The H9C2 cardiomyocytes were divided into blank control group, pcDNA-NC group, and lncRNA-B230352I09 overexpression group. Cell counting kit-8 (CCK8) was used to measure the absorbance (optical density, OD) of H9C2 cardiomyocytes at a wavelength of 450 nm and draw a growth curve; 5-ethynyl-2'-deoxyuridine (EdU) was used to label proliferating H9C2 cardiomyocytes, the numbers of which were observed by fluorescence microscopy. Cardiomyocyte cycle was assessed by flow cytometry and cycle-related genes expression was measured by RT-PCR.
·Compared with the pcDNA-NC group, the expression level of lncRNA-B230352I09 was significantly higher in the lncRNA-B230352I09 overexpression group (P=0.000), suggesting that the lncRNA-B230352I09-transfected H9C2 cardiomyocyte model was successfully constructed. Compared with the pcDNA-NC group, the CCK8 assay showed that lncRNA-B230352I09 overexpression significantly increased the OD of H9C2 cardiomyocytes and promoted the proliferation of H9C2 cardiomyocytes with a significant time-dependent enhancement of cell proliferation (24 h: P=0.000; 48 h: P=0.000; 72 h: P=0.001). Fluorescence microscopy revealed that the proportion of EdU-labeled positive H9C2 cardiomyocytes was significantly increased in the lncRNA-B230352I09 overexpression group compared to the pcDNA-NC group. Flow cytometric analysis showed a significant increase in the proportion of H9C2 cardiomyocytes in S phase and a decrease in G1 phase in the lncRNA-B230352I09 overexpression group compared to the pcDNA-NC group (P=0.000). RT-PCR showed that the mRNA expression levels of cyclin D1 and cyclin dependent protein kinase 1 (CDK1) in the lncRNA-B230352I09 overexpression group were significantly higher compared with the pcDNA-NC group (P=0.000).
·lncRNA-B230352I09 can enhance myocardial proliferative capacity by regulating cyclin D1 and CDK1 to promote the entry of cardiomyocytes to into S phase.
1 | VIRANI S S, ALONSO A, BENJAMIN E J, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association[J]. Circulation, 2020, 141(9): e139-e596. |
2 | TERINGOVA E, TOUSEK P. Apoptosis in ischemic heart disease[J]. J Transl Med, 2017, 15(1): 87. |
3 | ABBAS N, PERBELLINI F, THUM T. Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration[J]. Basic Res Cardiol, 2020, 115(5): 52. |
4 | WANG J, CHEN X D, SHEN D P, et al. A long noncoding RNA NR_045363 controls cardiomyocyte proliferation and cardiac repair[J]. J Mol Cell Cardiol, 2019, 127: 105-114. |
5 | CAI B, MA W, WANG X, et al. Targeting lncDACH1 promotes cardiac repair and regeneration after myocardium infarction[J]. Cell Death Differ, 2020, 27(7): 2158-2175. |
6 | CHEN Y M, LI H, FAN Y, et al. Identification of differentially expressed lncRNAs involved in transient regeneration of the neonatal C57BL/6J mouse heart by next-generation high-throughput RNA sequencing[J]. Oncotarget, 2017, 8(17): 28052-28062. |
7 | PORRELLO E R, MAHMOUD A I, SIMPSON E, et al. Transient regenerative potential of the neonatal mouse heart[J]. Science, 2011, 331(6020): 1078-1080. |
8 | MALIKEN B D, MOLKENTIN J D. Undeniable evidence that the adult mammalian heart lacks an endogenous regenerative stem cell[J]. Circulation, 2018, 138(8): 806-808. |
9 | ZHU F, MENG Q Y, YU Y, et al. Adult cardiomyocyte proliferation: a new insight for myocardial infarction therapy[J]. J Cardiovasc Transl Res, 2021, 14(3): 457-466. |
10 | PARADIS A N, GAY M S, ZHANG L B. Binucleation of cardiomyocytes: the transition from a proliferative to a terminally differentiated state[J]. Drug Discov Today, 2014, 19(5): 602-609. |
11 | IKENISHI A, OKAYAMA H, IWAMOTO N, et al. Cell cycle regulation in mouse heart during embryonic and postnatal stages[J]. Dev Growth Differ, 2012, 54(8): 731-738. |
12 | MOHAMED T M A, ANG Y S, RADZINSKY E, et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration[J]. Cell, 2018, 173(1): 104-116. |
13 | STACEY D W. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells[J]. Curr Opin Cell Biol, 2003, 15(2): 158-163. |
14 | KIMES B W, BRANDT B L. Properties of a clonal muscle cell line from rat heart[J]. Exp Cell Res, 1976, 98(2): 367-381. |
/
〈 |
|
〉 |